Household Healthcare Sector

DURECT

Market Cap: US$16.9m

A biopharmaceutical company, develops medicines based on its epigenetic regulator program.

SAB Biotherapeutics

Market Cap: US$16.8m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.

TherapeuticsMD

Market Cap: US$16.8m

Operates as a pharmaceutical royalty company in the United States.

Unidoc Health

Market Cap: CA$22.9m

Operates as a healthcare services company in Canada.

NEXGEL

Market Cap: US$16.7m

Manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

ProMIS Neurosciences

Market Cap: US$16.5m

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.

IRIDEX

Market Cap: US$16.5m

An ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

Beyond Air

Market Cap: US$16.4m

A commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform.

MedX Health

Market Cap: CA$22.0m

Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally.

Next Science

Market Cap: AU$24.5m

Engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.

GlycoMimetics

Market Cap: US$15.8m

Engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States.

Neurotech International

Market Cap: AU$24.1m

A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.

NKGen Biotech

Market Cap: US$15.6m

Operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies.

Allarity Therapeutics

Market Cap: US$15.5m

A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.

American Shared Hospital Services

Market Cap: US$15.3m

Provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.

Izotropic

Market Cap: CA$20.9m

A research and development company, develops diagnostic products for detecting breast cancers.

EMV Capital

Market Cap: UK£11.2m

A venture capital firm specializing in seed, growth capital, early and mid stage investments.

Lotus Pharmaceuticals

Market Cap: US$15.2m

Does not have significant operations.

Avem Health Partners

Market Cap: US$15.2m

Provides financial, technology, management, and capital solutions to hospitals in rural markets.

Exlites Holdings International

Market Cap: US$15.0m

Manufactures and distributes medical products.

Leap Therapeutics

Market Cap: US$15.0m

A biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.

Charlotte's Web Holdings

Market Cap: CA$20.6m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Calidi Biotherapeutics

Market Cap: US$14.9m

A clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.

Harvard Bioscience

Market Cap: US$14.9m

Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.

Cocrystal Pharma

Market Cap: US$14.9m

A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.

Advanced Health Intelligence

Market Cap: AU$22.6m

Operates as a mobile application and technology development company in Australia and internationally.

Precipio

Market Cap: US$14.6m

A healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.

PreveCeutical Medical

Market Cap: CA$20.0m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Equillium

Market Cap: US$14.5m

A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.

ProBiotix Health

Market Cap: UK£10.7m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Curative Biotechnology

Market Cap: US$14.4m

A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices.

IXICO

Market Cap: UK£10.7m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

MEI Pharma

Market Cap: US$14.4m

A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

Ventripoint Diagnostics

Market Cap: CA$19.6m

A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.

NextCure

Market Cap: US$14.2m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

Ernexa Therapeutics

Market Cap: US$14.2m

A preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease.